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The discovery of the colocalization of catalase with H2O2-generating oxidases in peroxisomes was the first indication of their involvement in
the metabolism of oxygen metabolites. In past decades it has been revealed that peroxisomes participate not only in the generation of reactive
oxygen species (ROS) with grave consequences for cell fate such as malignant degeneration but also in cell rescue from the damaging effects of
such radicals. In this review the role of peroxisomes in a variety of physiological and pathological processes involving ROS mainly in animal cells
is presented. At the outset the enzymes generating and scavenging H2O2 and other oxygen metabolites are reviewed. The exposure of cultured
cells to UV light and different oxidizing agents induces peroxisome proliferation with formation of tubular peroxisomes and apparent upregulation
of PEX genes. Significant reduction of peroxisomal volume density and several of their enzymes is observed in inflammatory processes such as
infections, ischemia–reperfusion injury and hepatic allograft rejection. The latter response is related to the suppressive effects of TNFα on
peroxisomal function and on PPARα. Their massive proliferation induced by a variety of xenobiotics and the subsequent tumor formation in
rodents is evidently due to an imbalance in the formation and scavenging of ROS, and is mediated by PPARα. In PEX5−/− mice with the absence
of functional peroxisomes severe abnormalities of mitochondria in different organs are observed which resemble closely those in respiratory chain
disorders associated with oxidative stress. Interestingly, no evidence of oxidative damage to proteins or lipids, nor of increased peroxide
production has been found in that mouse model. In this respect the role of PPARα, which is highly activated in those mice, in prevention of
oxidative stress deserves further investigation.
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1.1. The “good” and the “evil” of ROS
Oxidative stress arises from a significant increase in the
concentration of reactive oxygen species (ROS) and reactive
nitrogen species (RNS), and/or a decrease in their detoxification
mechanisms. There are many natural sources of oxidative stress,
for example exposure to environmental oxidants, toxins likeAbbreviations: ER, endoplasmic reticulum; iNOS, inducible nitric oxide
synthase; MnSOD, manganese superoxide dismutase; PBD, peroxisome
biogenesis disorder; PEX, peroxin; PMP, peroxisomal membrane protein;
PPAR, peroxisome proliferator activated receptor; PTS, peroxisomal targeting
signal; ROS, reactive oxygen species; TNF, tumor necrosis factor
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doi:10.1016/j.bbamcr.2006.09.006heavy metals, ionizing and UV irradiation, heat shock, and
inflammation [1]. High levels of ROS exert a toxic effect on
biomolecules such as DNA, proteins, and lipids (e. g., non-
enzymatic lipoperoxidation), thus leading to the accumulation
of oxidative damage in diverse cellular locations, to the
deregulation of redox-sensitive metabolic and signalling path-
ways, and to pathological conditions. Much interest in oxidative
stress comes from human pathologies, for example ischemia–
reperfusion injury, atherosclerosis, hypertension, inflammation,
cystic fibrosis, cancer, type-2 diabetes, or neurodegenerative
diseases such as Parkinson's or Alzheimer's disease. Further-
more, oxidative stress has been linked to aging [2]. Besides their
harmful role in clinical conditions, the importance of ROS
(RNS) as mediators in various vital cellular processes and cell
signalling pathways became apparent (reviewed in [3,4]). A
typical example is their function in apoptosis.
Fig. 1. (A) Fluorescence microscopy of peroxisomes and mitochondria, two
major subcellular organelles involved in the metabolism of ROS, in COS-7 cells,
a green monkey kidney cell line. Cells were stained with antibodies to
peroxisomal catalase (red) and to mitochondrial MnSOD (green). (B)
Mammalian cells can exhibit different peroxisomal morphologies under normal
culture conditions. Peroxisomes in COS-7 cells were visualized by immuno-
fluorescence using specific antibodies directed to PMP70, a peroxisomal
membrane protein. Note the spherical shape of peroxisomes in the cell at the left,
in contrast to their elongated, tubular morphology in the cell at right. The
formation of elongated peroxisomes is induced after UV irradiation or exposure
to H2O2 (see Section 4.2). (C, D) Electron micrographs of altered mitochondria
in hepatocytes of PEX5−/− mice (reprinted from [91] with permission from
Springer-Verlag) (C) Pleomorphic mitochondria with altered cristae. Some of
the round, large mitochondria exhibit stacks of parallel cristae (arrows). (D)
Mitochondria with circular cristae (asterisks) or mitochondrial ghosts (arrow).
Scale bars, 10 μm (A, B), 500 nm (C, D).
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electrons), such as the superoxide anion (O2·−), which is formed
through one-electron reduction of O2 (O2+e
−→O2·−). Hydro-
gen peroxide (H2O2) is also ascribed to ROS, although it has no
unpaired electrons, and thus is not a radical. It can, for example,
be formed by the dismutation reaction of O2·− (catalyzed by
superoxide dismutases) via the hydroperoxyl radical
(O2·−+H+→HO2·−; 2HO2·−→H2O2+O2). Probably the most
highly reactive and toxic form of oxygen, the hydroxyl radical
(·OH), can be formed by the metal ion (e. g., iron or copper)-
catalyzed decomposition of H2O2 (H2O2 + O2·−→O2+
OH−+·OH). Similarly, RNS include radical species such as
primary nitric oxide (·NO). ·NO and H2O2 are membrane
permeable, diffusible molecules, which are less-reactive and
longer-lived than·OH, thus being best suited for intra- and even
intercellular signalling. In particular H2O2, which is not harmful
until converted to more reactive ROS, acts on cellular thiol-
disulfide redox buffer systems such as glutathione, thioredoxin
and peroxiredoxin (for review see [5,6]).
1.2. Peroxisomes and ROS
Oxygen is consumed in various metabolic reactions in
different cellular locations, with mitochondria, the ER, and
peroxisomes being the major sites (Fig. 1A). De Duve and
Baudhuin [7] first described a respiratory pathway in peroxi-
somes, in which electrons removed from various metabolites
reduce O2 to H2O2, which is further reduced to H2O. The
respiratory pathway in peroxisomes is not coupled to oxidative
phosphorylation, and does not lead to the production of ATP.
Free energy is released in the form of heat.
The high peroxisomal consumption of O2, the demonstration
of the production of H2O2, O2·−,·OH, and recently of·NO in
peroxisomes [7–10], as well as the discovery of several ROS-
metabolizing enzymes in peroxisomes (see Tables 1 and 2) has
supported the notion that these ubiquitous organelles play a key
role in both the production and scavening of ROS in the cell, in
particular H2O2 (Fig. 2).
Initially, it was assumed that the main function of
peroxisomes was the decomposition of H2O2 generated by
different peroxisomal oxidases (mainly flavoproteins) via
catalase, the classical peroxisomal marker enzyme. However,
it is now clear that peroxisomes are involved in a variety of
important cellular functions in almost all eukaryotic cells (for
details see articles about peroxisomal metabolism, this issue).
The main metabolic processes contributing to the generation
of H2O2 in peroxisomes are the β-oxidation of fatty acids, the
enzymatic reactions of the flavin oxidases, the disproportion-
ation of superoxide radicals, and in plant peroxisomes, the
photorespiratory glycolate oxidase reaction. It has been
estimated that about 35% of all H2O2 formed in rat liver
derives from peroxisomal oxidases [11]. To degrade the ROS,
which are produced due to their metabolic activity, and to
maintain the equilibrium between production and scavenging
of ROS, peroxisomes harbour several powerful defense
mechanisms and antioxidant enzymes in addition to catalase
(Table 2, Fig. 2).An interesting feature of peroxisomes is their ability to pro-
liferate and multiply, or be degraded in response to nutritional
and environmental stimuli. In rodents, for example, the number
and size of peroxisomes as well as the expression of peroxisomal
Table 1
Enzymes in peroxisomes that generate ROS
Enzyme Substrate ROS
(1) Acyl-CoA oxidases
(a) Palimtoyl-CoA oxidase Long chain fatty acids H2O2
(b) Pristanoyl-CoA oxidase Methyl branched chain
fatty acids
H2O2
(c) Trihydroxycoprostanoyl-CoA
oxidase
Bile acid intermediates H2O2
(2) Urate oxidase Uric acid H2O2
(3) Xanthine oxidase Xanthine H2O2, O2·−
(4) D-amino acid oxidase D-Proline H2O2
(5) Pipecolic acid oxidase L-pipecolic acid H2O2
(6) D-aspartate oxidase D-aspartate,
N-methyl-D-aspartate
H2O2
(7) Sarosine oxidase Sarcosine, pipecolate H2O2
(8) L-alpha-hydroxy acid oxidase Glycolate, lactate H2O2
(9) Poly amine oxidase N-Acetyl spermine/
spermidine
H2O2
(10) Nitric oxide synthase L-Arginine ·NO
(11) Plant sulfite oxidase [165] Sulfite H2O2
Fig. 2. Schematic overview of peroxisomal enzymes which produce or degrade
ROS. H2O2 is mainly produced by several peroxisomal oxidases (e. g., acyl-CoA
oxidase which is involved in theβ-oxidation of fatty acids). H2O2 is decomposed
by catalase and glutathione-peroxidase (GPx) or converted to hydroxyl radicals
(·OH). Hydroxyl radicals can damage the peroxisomal membrane by lipid
peroxidation of unsaturated fatty acids. Hydroperoxides formed in this process
can be decomposed by catalase and glutathione-peroxidase. Superoxide anions
(O2·−) generated by peroxisomal oxidases (for example, xanthine oxidase (XOx))
are scavanged by manganese superoxide-dismutase (MnSOD) and by copper-
zink superoxide-dismutase (CuZnSOD). Nitric oxide synthase (NOS) catalyses
the oxidation of L-arginine (L-Arg) to nitric oxide (NO·). NO·can react with O2·−
radicals to form peroxynitrite (ONOO−), a powerful oxidant. H2O2 and NO·can
penetrate the peroxisomalmembrane and act in cellular signalling. Peroxiredoxin
1 and PMP20 are involved in the degradation of H2O2. Mpv17 and L-MP are
implicated in the regulation of peroxisomal ROS metabolism.
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peroxisome proliferator activated receptors (PPARs) like
fibrates or free fatty acids are applied [12]. Such conditions
are considered to generate peroxisome-induced oxidative stress,
which may overwhelm the antioxidant capacity and lead to
cancer. Furthermore, transition metal ions like iron and copper
are abundant in peroxisomesmainly in a complexed form. Under
certain conditions, these metal ions can be released (e. g., by
xenobiotics) and catalyze the formation of ·OH in the Fenton
reaction (Fe2+ +H2O2→Fe
3++OH−+·OH), thus leading to
lipid peroxidation, damage of the peroxisomal membrane and
loss of peroxisomal functions [13,14].
It is obvious that due to their oxidative metabolism,
peroxisomes are considered a source of oxidative stress.
However, peroxisomes can also respond to oxidative stress
and ROS, which have been generated in other intra- or
extracellular locations, most likely to protect the cell against
an oxidative damage. Furthermore, certain peroxisome-gener-
ated ROSmay act as mediators in intracellular signalling [15]. In
this review, we will address recent findings on the production
and decomposition of ROS in peroxisomes, the response of
peroxisomes to oxidative stress, peroxisome proliferation andTable 2
Enzymes in peroxisomes that degrade ROS
Enzyme Substrate Enzyme is also present in
(1) Catalase H2O2 Cytoplasm (e. g., erythrocytes) and
nucleus, mitochondria (rat heart only)
(2) Glutathione peroxidase H2O2 All cell compartments
(3) Mn SOD O2·− Mitochondria
(4) Cu, Zn SOD O2·− Cytoplasm
(5) Epoxide hydrolase Epoxides ER and cytoplasm
(6) Peroxireodoxin 1 H2O2 Cytoplasm, nucleus, mitochondria
(7) PMP 20 H2O2 Peroxisomes
(8) Plant ascorbate–
glutathione cycle
H2O2 Peroxisomes, chloroplasts, cytoplasm,
root nodule mitochondria
(plants only) [27]the induction of ROS, as well as a role of ROS in clinical
conditions, peroxisomal disease, and mouse models. A function
of peroxisomes in aging is addressed elsewhere [2]. We will
mainly focus on animal peroxisomes, but findings in plant cells,
where some of the peroxisomal functions in ROS metabolism
were first discovered, are also discussed.
2. Peroxisomal enzymes that generate ROS
The discovery of the co-localization of several H2O2
producing oxidases together with catalase in peroxisomes was
the first indication suggesting the participation of peroxisomes
in the metabolism of oxygen metabolites. It also led de Duve to
propose the term “peroxisome” for the designation of that
organelle [7]. In mammalian peroxisomes the major sources of
H2O2 production are the oxidases that transfer hydrogen from
their respective substrates to molecular oxygen (Fig. 2). In rat
liver, peroxisomes produce about 35% of all H2O2 [11] which
accounts for about 20% of total oxygen consumption [16]. The
occurrence of oxidases varies markedly in peroxisomes of
different cells, tissues and organs contributing to the heteroge-
neity of peroxisomes. Table 1 shows a compilation of enzymes
in peroxisomes producing H2O2 and O2·−. In addition, the
enzyme NO-synthase is included which was first discovered in
plant peroxisomes [17] with subsequent detection in animal
peroxisomes [10].
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The β-oxidation of fatty acids is the most important
metabolic process in peroxisomes contributing to the formation
of H2O2 [18]. Although the peroxisomal lipid substrates have
little significance as sources of metabolic fuel for the generation
of energy, they serve important physiological functions. The
different classes of lipids are metabolized by separate enzymes
with distinct substrate specificities [19]. Three separate oxidases
have been identified in rat liver for the degradation of (a) very
long straight chain fatty acids and prostaglandins; (b) 2-methyl
branched-chain fatty acids; and (c) bile acid intermediates. An
important aspect of peroxisomal lipid metabolism is its
inducibility by a variety of endogenous and exogenous
substrates via the nuclear transcription factor PPARα which
can in turn induce tumor formation [20].
2.2. Urate oxidase
This enzyme, which in most mammalian species is localized
in the electron dense crystalline cores of hepatic peroxisomes
[21,22] catalyses the oxidation of urate yielding H2O2,
allantoin, and CO2, which is the final step in the metabolic
degradation of the purine ring in many mammalian species. In
humans and primates the enzyme has lost its activity because of
multiple mutations of the urate oxidase gene [23]. Because of
the antioxidant properties of urate it has been postulated that the
loss of the enzyme in humans may have a protective effect
against conditions associated with ROS such as cancer and
aging [24].
2.3. Xanthine oxidase
There are two functionally distinct forms of this enzyme: the
NAD+ dependent ‘D’ or the dehydrogenase form, and the O2-
dependent ‘O’ or the oxidase form. Under a variety of
conditions such as proteolysis, heating and ischemia the D
form is transformed to the O form [25] which can generate the
toxic superoxide radical as well as H2O2. The oxidase activity
was demonstrated in rat liver peroxisomes by the cerium
technique [26]. In addition, the enzyme activity was found in
the cytoplasm of hepatic endothelial cells as well as in plant
peroxisomes [27].
2.4. D-amino acid oxidase
This flavoprotein exhibits a mosaic pattern in rat liver with
strongly and weakly stained peroxisomes in hepatocytes [28].
The intensity of staining is stronger in periportal than in
perivenous regions of the liver lobule. In addition, the enzyme is
present in rat brain and kidney [29]. In kidney proximal tubules
the enzyme occupies mostly the central part of the matrix of
peroxisomes forming a distinct subcompartment [30,31]. In
marine mussel, Mytilus galloprovincialis, D-amino acid oxidase
is present in peroxisomes of the digestive gland cells and is
markedly induced after exposure to pollutants such as lubricant
oil and phthalates [32]. In addition, the enzyme is found indigestive glands of terrestrial gastropods next to D-aspartate
oxidase [33].
2.5. D-aspartate oxidase
This is another flavoenzyme that specifically oxidizes the D-
amino acids with two carboxylic groups such as D-aspartate, D-
glutamate and N-methyl-D-aspartate with important neuroregu-
latory functions in the central nervous system. The enzyme has
been localized in rat and human brain with strong activity in the
hypothalamic paraventricular nucleus [34] as well as in rat liver
and kidney peroxisomes [35]. The rat liver enzyme has an
inherent targeting signal (SKL) for import into peroxisomes
[34].
2.6. Pipecolic acid oxidase
This enzyme catalyses the oxidation of L-pipecolic acid to
piperidine-6-carboxylic acid generating H2O2 and was localized
to renal and hepatic peroxisomes [36]. The cloning of both
human and rat proteins revealed that the enzyme is related to the
bacterial sarcosine oxidase rather than to D-amino acid oxidase
[37]. In peroxisomal deficiency disorders the level of pipecolic
acid is elevated, although this does not seem to be a specific
diagnostic feature [38].
2.7. Sarcosine oxidase
This flavoprotein was cloned from rabbit kidney and was
noted to oxidize not only sarcosine but also L-proline as well as
L-pipecolic acid [39]. By cytochemistry the enzyme was
localized to liver and kidney peroxisomes of several mamma-
lian species including mouse and hamster [40]. In plants
(Arabidopsis) the enzyme metabolizes both sarcosine and
pipecolate with preferential utilization of the latter as an
endogenous substrate [41].
2.8. L-alpha-hydroxy acid oxidase
There are two isoforms of this enzyme with the A-isoform
oxidizing preferentially glycolate and being most prominent in
liver, and the B-isoform occurring in kidney and utilizing DL-
hydroxybutyrate as substrate [42,43]. In kidney the enzyme is
localized to marginal plates which are crystalline plate-like
structures just below the peroxisomal membranes [44]. By
genomic analysis three distinct human genes were identified
with significant sequence similarity to plant glycolate oxidase
[45]. Hydoxy acid oxidase 1 is a liver specific enzyme with a
modified peroxisomal targeting signal consisting of SKI [46]. It
oxidizes glycolate to glyoxylate and its mRNA is significantly
reduced in rats subjected to oxidative stress induced by
ischemia and reperfusion or by glutathione depletion [47].
2.9. Polyamine oxidase
The mammalian enzyme utilizes both spermine and
spermidine as substrates [48] and exerts an important influence
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increased in tumors [49]. The murine and bovine enzymes were
cloned and found to contain type 1 peroxisomal targeting
signals at their C terminals [50].
2.10. Nitric oxide synthase
This enzyme generates nitric oxide (·NO), a molecule with
important signalling functions in animals and plants. In plant
cells the enzyme was localized to peroxisomes [17] and seems
to be involved in various important physiological processes
such as development, growth, senescence and innate immunity
[51–53]. In animal cells, an inducible form of the enzyme
(iNOS) is expressed under pathological conditions which can
cause severe tissue injury. Stolz et al. [10] reported the detection
of iNOS in peroxisomes of rat hepatocytes after exposure to
tumor necrosis factor-alpha. Because of the concomitant
reduction of catalase activity the possibility of the formation
of the highly toxic peroxynitrite radical was suggested.
Recently, however, it was noted that the peroxisomal pool of
iNOS consists mostly of the inactive monomeric form,
suggesting that the peroxisomal sequestration could prevent
the formation of the more toxic dimeric form in the cytoplasm
[54]. The exact mechanism of transport of iNOS into
peroxisomes is not known, although variations of both PTS1
and PTS2 have been described [10].
3. Peroxisomal enzymes that scavange ROS
Table 2 summarizes the enzymes in peroxisomes that
decompose ROS.
3.1. Catalase
This classical marker enzyme of peroxisomes metabolizes
both H2O2 (catalatic function) and a variety of substrates such as
ethanol, methanol, phenol and nitrites by peroxidatic activity
[55]. In most mammalian cells it is targeted to peroxisomes via a
modified PTS1 [56]. Catalase has an important protective
function against the toxic effects of peroxides generated in
peroxisomes and removes them with high efficiency [57]
(Fig. 1A). Indeed, the inhibition of catalase in rat liver sup-
presses markedly the peroxisomal lipid β-oxidation activity [58]
and in plant cells inhibits the glyoxylate cycle enzymes isocitrate
lyase and malate synthase [59]. Whereas the lack of peroxisomal
catalase in C. elegans causes developmental abnormalities and a
progeric phenotype [60], its overexpression in transgenic mice
induces an extension of the average lifespan of animals [61,2].
The catalase activity and peroxisomes are significantly reduced
in tumors of the liver [62] and other organs [63], as well as in a
variety of pathological processes such as liver allograft rejection
[64], and after ischemia–reperfusion injury [65].
3.2. Glutathione peroxidase
This is primarily a cytosolic enzyme which was also
detected in peroxisomes in rat liver [66]. It catalyses thedestruction of H2O2 with concomitant conversion of
reduced glutathione (GSH) to glutathione disulfide
(GSSG). It can also oxidize peroxide substrates such as
cumene hydroperoxide.
3.3. Manganese superoxide dismutase (MnSOD)
In most eukaryotic cells this enzyme is primarily localized in
mitochondria (Fig. 1A) but in addition it was reported in rat
liver peroxisomal membranes [67]. In higher plants the enzyme
was first localized in peroxisomes [68]. More recently, the
involvement of MnSOD in plant senescence was reported, and
it was found that the mitochondrial and peroxisomal enzyme are
differentially regulated [69]. A novel peroxisomal membrane
protein (M-LP) has been reported to up-regulate the expression
of MnSOD in COS-7 cells [70].
3.4. Copper Zinc superoxide dismutase (Cu, Zn SOD)
The localization of this enzyme in peroxisomes was first
detected by immuno-electron microscopy [71] and was
subsequently confirmed by cell fractionation [72]. The
expression of the gene can be induced by ciprofibrate as well
as by arachidonic acid and is mediated by a peroxisome
proliferator response element (PPRE) [73].
3.5. Epoxide hydrolase
This enzyme is present in peroxisomes and cytoplasm in
addition to the ER [74]. The rat liver enzyme contains a
modified PTS1 consisting of Ser–Lys–Ile [75]. The enzyme in
peroxisomes can catabolize fatty acids with an oxirane ring
which is formed in sterol metabolism and is inducible by
ciprofibrate [76].
3.6. Peroxiredoxin I
This antoxidant protein has thioredoxin-dependent peroxi-
dase activity with strong affinity for the pro-oxidant heme [77].
The presence of peroxiredoxin 1 in rat liver peroxisomes, in
addition to cytoplasm, mitochondria and nucleus was reported
recently [78]. The peroxiredoxins play an important role in
cellular protection against oxidative stress and in cell signalling
[79]. The expression of thioredoxins is induced by the ligand
activation of PPARα while overexpression of thioredoxins
inhibits the PPARα activity suggesting an auto-regulatory
mechanism [80].
3.7. Peroxisomal membrane protein 20 (PMP 20)
In addition to the above mentioned enzymes, a human and
mouse protein with peroxisomal targeting signal SQL, which
is similar to the PTS1, has been isolated exhibiting thiol-
specific antioxidant activity [81]. This PMP 20 is capable to
remove H2O2 by its thiol-peroxidase activity and has been
suggested to protect peroxisomal proteins against oxidative
stress.
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4.1. Alterations of ROS-metabolizing enzymes
An elevation of the environmental oxygen concentration has
been shown to induce a moderate increase in the volume density
of peroxisomes and their enzymes involved in the scavenging of
ROS. Chinese hamster ovary (CHO) cells exposed to 99% O2
exhibit a two-fold increase of the volume fraction of peroxi-
somes and two–four fold elevations of catalase, glutathione
peroxidase as well as manganese- and copper zinc-SODs [82].
On the other hand, more pronounced proliferation of peroxi-
somes and many-fold induction of H2O2-generating fatty acyl-
CoA oxidase activity is observed after treatment with
peroxisome proliferating chemicals [12,83] (see Section 5).
Whereas the mechanism of induction of oxidative enzymes in
peroxisomes via the nuclear transcription factor PPARα and its
co-activators [20] is now better understood, their response to
ROS is much more complex requiring further research. The
regulation of anti-oxidant enzymes is closely related to
apoptotic signalling because the oxidative state can determine
the cell fate to enter either the cell cycle or to undergo apoptosis
[84]. Indeed, elevation of anti-oxidative enzymes can suppress
apoptosis but this can also promote carcinogenesis [85]. On the
other hand, low levels of anti-oxidant enzymes such as catalase,
glutathione peroxidase and MnSOD are a typical hallmark of
malignant cells [86,62]. Thus, it seems that the regulation of
anti-oxidant enzymes is a more complex process in comparison
to that of oxidative enzymes which are mainly regulated by
PPARα. One of the forkhead transcription factors that protects
quiescent cells from oxidative stress is FOXO3a (also known as
FKHR-L1) which induces MnSOD [87]. Recently, it was
reported that the same transcription factor also regulates the
expression of the peroxisomal sterol carrier protein 2 (SCP2)
which is supposed to protect fatty acids from lipid peroxidation
[88]. Furthermore, the peroxisomal membrane proteins Mpv17
and M-LP (Mpv17-like protein), have been implicated in
regulating the expression of antioxidant enzymes in mammals
[9,70,89] (see Section 6).
4.2. Peroxisome elongation and protection against ROS
In cultured cells, oxidative stress has been shown to induce
morphological changes of the peroxisomal compartment. In
mammalian and plant cells a pronounced elongation of
peroxisomes is observed after UV irradiation, direct exposure
to H2O2, or even during live cell imaging of GFP-PTS1 labeled
peroxisomes by regular fluorescent light [90–93]. Antioxidant
treatment blocked the elongation of peroxisomes, thus support-
ing the role of ROS in UV-mediated peroxisomal growth [90].
Peroxisomes are highly dynamic organelles with large plastic-
ity, and spherical as well as elongated-tubular or tubulo-reticular
peroxisomal structures have been frequently described in
ultrastructural and light microscopic studies, even in live cells
(Fig. 1B). Evidence has been presented in the last years that
peroxisome elongation appears to be an important prerequisite
of peroxisome division, and that tubulation and fission ofelongated peroxisomes represent processes of peroxisomal
growth and division, which contribute to peroxisome prolifer-
ation. The molecular machinery involved in these processes is
just beginning to emerge. Recently, a role for the peroxisomal
membrane protein Pex11p, the dynamin-like protein DLP1/
Drp1, and Fis1, a putative membrane receptor/adaptor for
DLP1/Drp1 at the peroxisomal membrane has been demon-
strated [94–99]. Elongated/tubular peroxisomes can also be
induced by partial hepatectomy [100], stimulation of cultured
cells with defined growth factors or polyunsaturated fatty acids
(PUFAs), particularly arachidonic acid [90], microtubule
depolymerization [101], Pex11p overexpression [92,102], or
by inhibition of DLP1/Drp1 or hFis1 function [94–98].
Whereas the latter manipulations appear to act directly on the
peroxisomal membrane, the other conditions require intracel-
lular signalling to induce peroxisome elongation/growth [103].
Arachidonic acid, for example, is a substrate for peroxisomal β-
oxidation, but has also been shown to stimulate ROS production
by cultured cells [104]. In plant cells (but also in mammals) it is
suggested that diverse types of stress (e. g., wounding, pathogen
attack, drought, osmotic stress, excess light) that generate H2O2
as a signalling molecule result in peroxisome proliferation via
the up-regulation of PEX genes required for peroxisome
biogenesis and import of proteins [27,105,106]. An elevation
of peroxisomal SOD and glutathione peroxidase has been
reported after induction of oxidative stress by endotoxin
treatment of rat liver [107]. In plant cells, ROS and NO that
are generated and released to the cytosol by peroxisomes, are
suggested to target the nuclear proteins DET1 and COP1, which
are involved in photomorphogenesis [108]. They negatively
regulate the transcription of many light responsive genes
involved in peroxisomal functions, in light signalling, photo-
synthesis and in stress response [108,109]. However, most of
the UV- or ROS-mediated signalling pathways and the gene
responses leading to peroxisome elongation/proliferation are
still largely unknown. Although information on the exact
functions of elongated/tubular or complex peroxisomal struc-
tures is scarce, the evidence of ROS-mediated peroxisome
elongation/proliferation and induction of peroxisomal genes
supports an involvement in cellular rescue from ROS.
In Arabidopsis cells, the active sites for the antioxidant
enzymes ascorbate peroxidase and monodehydroascorbate
oxidase, are located on opposite sides of the peroxisomal
membrane, thus requiring diffusion of ROS across the
peroxisomal membrane for interaction [110]. The increased
membrane to matrix surface area ratio of elongated peroxisomes
may increase the accessibility of H2O2 or ascorbate free radical
to these enzymes [92]. Peroxisome elongation induced by ROS
must therefore not necessarily be accompanied by an elevation
of the antioxidative peroxisomal enzymes to allow efficient
decomposition of ROS. Furthermore, a CHO cell mutant with
an inactivating point mutation in DLP1/Drp1, which exhibited
permanently elongated peroxisomes and mitochondria, showed
resistance to oxidative stress and apoptotic stimulation [98]. On
the other hand, peroxisome elongation can lead to an increase in
the number of peroxisomes/proliferation by fission. Along the
same line, Wy-14463 induced peroxisome proliferation
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shown to prevent ROS production in hippocampal neurons and
to protect from β-amyloid neurodegeneration [111]. Finally,
ether phospholipid (plasmalogen) synthesis might be promoted
by peroxisomal elongation/proliferation after exposure to UV
light or H2O2. Plasmalogens have been implicated in the
protection against oxidative stress and in an important anti-
oxidative function in biomembranes [112,113]. An important
role of peroxisomes in defense against ROS is demonstrated by
the high sensitivity to UV-irradiation of mutant CHO cells
defective in plasmalogen synthesis [114], and cells from
patients with peroxisome biogenesis disorders (PBDs) with
low levels of plasmalogens [115–117]. It has to be noted, that
certain signalling lipids are derived from ether phospholipids
(e. g., platelet activating factor), which act on several cellular
signalling cascades and can influence ROS equilibrium
indirectly [118].
4.3. Peroxisomes in inflammation, ischemia–reperfusion injury
and related conditions
Hyperlipidemia is a hallmark of bacterial infections and it
was suggested to be related to the elevation of the cytokine
TNFα [119]. In rat liver TNFα suppresses markedly the
expressions of catalase and other peroxisomal proteins [120]
with simultaneous reduction of the mRNAs for peroxisomal
lipid β-oxidation enzymes as well as for PPARα [121].
Significant reduction of the volume density of peroxisomes
and several of their enzymes in liver was also reported in rats
with pneumococcal sepsis [122]. Endotoxin treatment also
reduced significantly the peroxisomal metabolism of lipids and
fatty acids [123].
Another closely related pathological process associated with
severe oxidative stress is the ischemia and reperfusion injury
[124]. Peroxisomes from rat kidney [125] and liver [126]
exposed to ischemia and reperfusion exhibited significant loss
of catalase and lipid β-oxidation enzymes. Marked reduction of
catalase and fatty acyl-CoA oxidase activities with structural
alterations of peroxisomes were also reported in acute rejection
of rat liver allografts [64]. Similar impairment of peroxisomal
functions have also been reported in the central nervous system
of rats with an experimental autoimmune encephalomyelitis
[127]. The loss of peroxisomal functions in all above mentioned
models could lead to the accumulation of harmful metabolites of
arachidonic acid further intensifying the cell injury and
inducing an inflammatory response.
Because of the central role of peroxisomes in the catabolism
of inflammatory lipid mediators like leukotriene B4 [128], the
impairment of peroxisomal function can contribute significantly
to the prolongation and intensification of the inflammatory
process. This is supported also by the observation of chronic
inflammation with fibrosis/cirrhosis in the liver of children with
Zellweger syndrome [129]. In this respect the activation of
PPARα by leukotriene B4 [130] serves to limit the inflamma-
tory process, providing a physiological mechanism to stop the
damaging effects associated with inflammation [131]. This
notion is confirmed by the demonstration of the important roleof PPARα in the regulation of the inflammatory response in
ischemia–reperfusion injury of liver [132]. In mice nullizygous
for PPARα the extent of liver damage is significantly greater
than in wild type littermates, and the expression of iNOS after
ischemia–reperfusion is much less. Moreover, the treatment of
normal mice with the PPARα agonist, WY-14643, reduces
significantly the severity of liver pathology. The same PPARα
agonist also is highly effective in treatment of dietary
steatohepatitis in mice which results from the action of ROS
on accumulated lipids and excessive formation of lipoperoxides
in the liver [133]. In brain also, Wy-14643 prevents the β-
amyloid related neuronal degeneration induced by ROS [111].
The above observations demonstrate clearly the participation
of peroxisomes in the pathophysiology of inflammation and the
protective role of their induction via the PPARs in limiting the
damaging effects of this important pathologic process. It is
almost impossible to dissect out the role of peroxisomes alone in
the pathophysiology of the inflammatory process since PPARα
induces not only several peroxisomal proteins but also affects
the transcription of other genes such as those of mitochondrial
and microsomal enzymes as well. Although the details of the
cellular responses to activation of PPARs by their internal
ligands, particularly the lipid mediators, and their effects upon
cell and tissue injury and repair are just beginning to emerge
[134], that information shall have a great impact on the
development of novel therapeutic concepts in inflammation and
repair processes [135].
5. Peroxisome proliferation and induction of oxidative
stress
The massive proliferation of peroxisomes in the liver of rats
treated with the hypolipidemic drug clofibrate was the first
indication of a possible involvement of this organelle in the lipid
metabolism in mammalian liver [136]. Since the central role of
peroxisomes in β-oxidation of fatty acids in plant cells was at
that time quite well known [137], the observations with
clofibrate in rat liver led to the discovery of lipid β-oxidation
in animal peroxisomes [138]. The list of compounds inducing
peroxisome proliferation is quite long and includes hypolipi-
demic drugs, industrial chemicals such as plasticizers and
lubricants as well as agrochemicals and many toxic environ-
mental pollutants [139]. Selective transcription of peroxisomal
genes by those chemicals is mediated by PPARα, which
belongs to the family of nuclear transcription factors [140].
Whereas the expression of the genes of the lipid β-oxidation,
particularly of acyl-CoA oxidase, is induced very strongly (10–
30 fold depending on compound and dosage), the maximal
induction of catalase does not exceed 1–2 fold [12,141]. The
disproportionate increase of H2O2-generating oxidases, partic-
ularly of fatty acid oxidase, in comparison to H2O2-scavenging
catalase was suggested to be responsible for oxidative stress
leading to the development of hepatic tumors in rodents treated
with peroxisome proliferating compounds [83]. This notion was
supported by in vitro studies using cultured cells transfected
with cDNA for acyl-CoA oxidase and exposed subsequently to
a fatty acid substrate. Indeed, the prolonged exposure to
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which formed distinct tumors after injection to nude mice [142].
The oxidative stress however, does not seem to be the sole
factor responsible for the development of tumors in rodents
exposed to peroxisome proliferators as additional parameters
such as potency to induce cell proliferation or to promote
initiated cells are also of great importance [143]. Moreover,
other factors such as suppression of apoptosis [144], perturba-
tion of cell proliferation, and release of superoxide radicals from
Kupffer cells [145] have also been suggested to play roles in the
pathogenesis of tumors associated with peroxisome prolifera-
tion [146]. The central event in the carcinogenesis, however,
seems to be the activation of PPARα [147], and indeed, the
PPARα−/− mice are refractory not only to the peroxisome
proliferating effect but are also resistant to hepato-carcinogen-
esis when fed a diet containing a potent non-genotoxic
carcinogen such as WY-14643 [148]. Along the same line, the
low level of PPARα in livers of primates and humans seems to
be responsible for the resistance of those species to the
carcinogenic effect of peroxisome proliferating compounds
[149], although their lipid lowering effect is not affected by that
[150,151].
6. Mouse models, peroxisomal disorders, and ROS
In recent years, several PEX gene knockout-mouse models
(e. g., PEX2, 5, 7, 11α, 11β, 13) have been developed to study
peroxin loss/function and the pathogenetic mechanisms of PBDs
[152]. PEX5−/− mice, which have been generated by disrupting
the PEX5 gene encoding the PTS1 receptor for most
peroxisomal matrix proteins, show a severe peroxisomal import
defect, lack morphologically identifiable peroxisomes, and
exhibit the typical biochemical abnormalities and pathological
defects of Zellweger patients [153]. In addition, marked
mitochondrial abnormalities were observed in various organs
of the PEX5−/− mice (e. g., liver, kidney, adrenal cortex, heart)
and specific cell types (skeletal and smooth muscle cells,
neutrophils) [154]. Ultrastructural studies revealed the prolifer-
ation of pleomorphic mitochondria with alterations of the cristae
and the outer mitochondrial membrane (Fig. 1C, D). Similar
mitochondrial alterations, especially of the inner mitochondrial
membrane, were also observed in hepatocytes using a mouse
model with hepatocyte-selective elimination of peroxisomes (by
inbreeding Pex5–loxP and albumin–Cre mice) (L-PEX5−/−)
[155]. Such ultrastructural alterations of mitochondria have also
been found in respiratory chain disorders [156], and other
diseases associated with oxidative stress [157]. Biochemically,
changes in the expression and activities of mitochondrial
respiratory chain complexes, and a marked increase of
mitochondrial MnSOD were described in PEX5−/− mice [154].
Furthermore, apoptosis of neuronal cells was highly increased in
the brain of the PEX5−/− mouse [153]. In L-PEX5−/− mice,
severely reduced activities of complex I, III, an V and a
collapse of the mitochondrial inner membrane potential were
reported [155]. No disturbance of the ATP levels and redox
state of the liver but a compensatory increase of glycolysis and
mitochondrial proliferation were detected [155]. It has beensuggested that an increased production of ROS in altered
mitochondria in combination with defective peroxisomal
antioxidant mechanisms and the accumulation of lipid
intermediates of the peroxisomal β-oxidation system, might
contribute to the pathogenesis of Zellweger syndrome [154].
However, neither increased peroxide production, oxidative
damage to proteins or lipids, nor elevation of oxidative stress
defense mechanisms were found in L-PEX5−/− hepatocytes
[155]. In line with this, evidence for increased oxidative stress
was reported in fibroblasts of patients with multifunctional
protein-2 deficiency, a peroxisomal β-oxidation defect, but not
in patients with a PBD [158]. Furthermore, mitochondria of the
PEX2−/− mouse, which has a remarkably similar clinical,
biochemical and cellular phenotype as the PEX5−/− mouse,
appear to be normal [159]. Another model, which links
peroxisomal ROS production to kidney disease, is the
MPV17−/− mouse. MPV17−/− mice have been reported to
develop age-dependent hearing loss and severe renal failure
owing to glomerular sclerosis [9]. Mpv17 has been localized to
the peroxisomal membrane, and implicated in the regulation of
peroxisomal ROS metabolism. Loss of the Mpv17 protein does
not impair peroxisome biogenesis but instead leads to a
reduced ability to produce ROS, whereas overexpression
results in dramatically enhanced levels of intracellular ROS
[9]. These findings have been challenged by a recent report,
where Mpv17 has been localized to the inner mitochondrial
membrane, and its absence or malfunction has been linked to
oxidative phosphorylation failure and mtDNA depletion [160].
If this discrepancy is related to different Mpv17 isoforms,
splice variant, or dual targeting, has to be elucidated.
7. Perspectives
The central role of peroxisomes in the generation and
scavenging of H2O2 has been well-known ever since their
discovery almost five decades ago. Recent studies, particularly
in plant cells, have now revealed their involvement in the
metabolism of ROS and nitric oxide that have important
functions in intra- and inter-cellular signalling. Apparently,
peroxisomes can have two ambivalent roles in the cell, as
generators of oxidative stress and as a source of ROS signal
mediators. It will be a great challenge for the future to dissect
the UV- or ROS-mediated signalling pathways and the gene
responses regulating peroxisomal metabolism, biogenesis and
disease. These approaches require novel techniques and
improved tools, which are partially available. For example, a
new chemiluminescence method for a sensitive and real-time
determination of H2O2 metabolism in suspensions of intact
peroxisomes has been developed [161]. Furthermore, studies to
assess the pH or the hydroxyl-radical formation in peroxisomes
of living cells by targeting peptide-conjugated fluorophores
carrying a PTS1 have been reported [162–164].
There is growing evidence for a role of peroxisomes in a
variety of physiological and pathological processes involving
ROS, particularly the participation of peroxisomes in the
pathophysiology of inflammation and the protective role of their
induction via the PPARs in limiting oxidative injury. Molecular
1763M. Schrader, H.D. Fahimi / Biochimica et Biophysica Acta 1763 (2006) 1755–1766details on the cellular responses to the activation of PPARs by
their internal ligands, particularly the lipid mediators, and their
effects upon cell and tissue injury and repair processes are just
beginning to emerge [134]. In this respect, a novel area of
medical research with prospects of vast therapeutic applications
is developing [135], that deserves a great deal of attention.
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